Year End Offer

Global Organ-on-Chips Market By Type (liver, heart, lungs and others); By Application (drug discovery, toxicology research and other applications); By end-user (Pharmaceutical and biotechnology companies, academic and research institutes and others) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030.

About the Report

About the Report

Product overview

Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates activities, mechanics, and physiological responses of the organ system. It is the size of a AA battery that allows seeing the functionality of organs, their behavior and response at the molecular and cellular level.

Market highlights

Global Organ-on-a-Chip Market grew at USD XXX million in 2019 and is expected to grow at a CAGR of XX% in the forecasted period. An increase in animal testing, research funding, capital investments, new product launches, and a rise in technological investments is likely to increase the growth of the market.

Source: Fatpos Global

Global Organ-on-Chips Market: Segments

Global Organ-on-a-Chip Market can be segmented on the basis of type, application, end-user, and regions.

By organ type, it can be categorized into the liver, heart, lungs, and others. The liver segment shows significant growth due to the increased liver-related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.

By application, it can be segmented into drug discovery, toxicology research, and other applications. Technological advancements and an increase in drug toxicity demand are reasons for the growth of the drug segment.

Global Organ-on-a-Chip Market by end-user is divided into Pharmaceutical and biotechnology companies, academic and research institutes, and others. Increasing research investment in the pharmaceutical sector across is likely to dominate the growth in the sector

The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.

Global Organ-on-Chips Market: Drivers and Restraints

High usage is expected to increase the market size

The growing usage of the organ-on-chips market for animal testing and in the healthcare sector and a rising number of alliances between the pharmaceutical firms and chips manufacturers are expected to increase market growth. Additionally, technological advancements and an increase in drug toxicity demand is also a driver in the market.

Technical issues and high costs will restrain the market growth

There are a lot of technical problems linked with organ-on-chips technology which acts as a restraint in the market along with the high cost as well as complexities in the organ-on-chip model. Restrictions in polydimethylsiloxane which is the most commonly used material for fabrications of the organ-on-chips market also acts as a hindrance in the growth of the market.

Global Organ-on-Chips Market: Regions

The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.

North America holds the largest share in the organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world-class research institutes and pharmaceutical and biotechnology industries in the region. Though, the APAC region is expected to become the fastest-growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.

Source: Fatpos Global

Global Organ-on-a-Chip Market is further segmented by region into:

North America Market Size, Share, Trends, Opportunities-o-Y Growth, CAGR – United States and Canada

Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America

Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe

APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC

MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global Organ-on-Chips Market: Key players

  •  Nortis
    • Business Strategy
    • Key Product offerings
    • Financial performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    •  SWOT Analysis
  • Organovo Holdings, Inc.
  • Hurel Corporation
  • Insphero AG
  • MIMETAS BV
  • Mimetas
  • Emulate
  • InSphero
  • Ascendance Bio
  • AxoSim

Global Organ-on-a-Chip Market report also contains analysis on:

Global Organ-on-Chips Market segments:-

  • By type :
    • Liver
    • Lungs
    • Heart
    • others
  • By application :
    • drug discovery
    • toxicology research
    • other applications
  • By end-user :
    • Pharmaceutical and biotechnology companies
    • academic and research institutes
    • others
  • Global Organ-on-Chips Market dynamics
  • Global Organ-on-Chips Market size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

FAQs on Global Organ-on-Chips Market

  • Which segment is anticipated to hold the largest market share?
  • At what CAGR is the market anticipated to grow between 2020 and 2030?
  • Who are the key players in Global Organ-on-Chips Market?
  • What could be the challenging factors for the growth of Global Organ-on-Chips Market?
  • What are the growth drivers for Global Organ-on-Chips Market?

Products

Table of Contents

Table of Contents

Contents        

  1. Executive Summary
  2. Global Organ-on-Chips Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  6. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  7. Recent Development, Policies & Regulatory Landscape
  8. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  9. Global Organ-on-Chips Market Analysis
    1. Porters Five Forces
      1. The threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  10. Global Organ-on-Chips Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11. Global Organ-on-Chips Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. The Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By Type: Market Share (2020-2030F)
      1. Liver, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Lungs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Heart, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3. By End User: Market Share (2020-2030F)
      1.  Pharmaceutical and biotechnology companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Academic and research institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    4. By Biotechnology: Market Share (2020-2030F)
      1. Public, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Private, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    5. By Application: Market Share (2020-2030F)
      1. Drug Discovery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Toxicology Research, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. Company Profile
    1. Nortis
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Organovo Holdings, Inc.
    3. Hurel Corporation
    4. Insphero AG
    5. MIMETAS BV
    6. Emulate
    7. InSphero
    8. Ascendance Bio
    9. AxoSim
  13. Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022


Trusted By 2500+ Brands

What Our Clients Say About Us